Service Areas
LCMS Bioanalysis, Immunoanalysis, Molecular Analysis, Pharmacology, In Vivo Services.
Specializing in the high volume of small, fast-turnaround studies that drive early drug development, we’ve integrated specialized processes for method development, study execution, and data delivery so you’ll hit your next milestone faster and with confidence.
You need speed without sacrificing data integrity. Your programs deserve a dedicated environment—not one squeezed by large-scale projects or burdened with inappropriate regulatory overhead.
Meadowhawk offers state-of-the-art LCMS bioanalysis, immunoanalysis, molecular analysis, oncology models, and rodent in vivo services to support the full array of drug modalities. Our fit-for-purpose approach ensures that we optimize each program based on its unique characteristics and your specific needs.
LCMS Bioanalysis, Immunoanalysis, Molecular Analysis, Pharmacology, In Vivo Services.
New chemical entities, therapeutic peptides/ proteins, therapeutic antibodies, nucleotides, biomarkers, lipid nanoparticles and others.
Exploratory Analysis, Lead Optimization, and IND Enabling Studies, each optimized for the specific needs of that stage.
Our proprietary approach yields operational savings and accelerated data flow. Unlike nationwide CROs, Meadowhawk offers all critical non-GLP services within our local Boston/San Francisco life science hubs – functioning as a seamless, high-speed extension of your own lab. With peer-to-peer support, a dedicated scientist, custom-tailored study design, and seamless integration of in vivo, LCMS, and molecular assays, our fully integrated service model provides PK/PD, LCMS, and molecular assays under one roof.
Learn More